BioCryst Pharmaceuticals, Inc. stands in solidarity with the HAE community by participating in the annual HAE Global Walk. Since actual community walks cannot currently be organized, BioCryst employees around the world are joining virtually with others supporting hae day :-) by logging their steps and photographing their activities to raise awareness of HAE.
“hae day :-) is an important part of HAE International’s comprehensive global awareness-raising initiative to facilitate faster diagnosis and access to life-saving HAE therapies,” says Henrik Balle Boysen, executive vice president and chief operating officer of HAE International.
“We have heard consistently from HAE patients and their physicians that an oral prophylactic therapy would be life-changing. With potential approvals of oral, once-daily berotralstat beginning around the world later this year, and the exceptional commercial team we are building, BioCryst is excited to deliver our innovative new therapy to them,” said Charlie Gayer, chief commercial officer of BioCryst.